Thor submits its BPR dossier for Union Authorisation of the C(M)IT/MIT Biocidal Product Family
In the first week of June Thor submitted a BPR1 dossier for Union Authorisation of the C(M)IT/MIT2 Biocidal Product Family including more than 20 ACTICIDE® products.
Following the publication of the Commission Implementing Regulation (EU) 2016/131 of 1 February 2016 approving C(M)IT/MIT as an existing active substance for use in biocidal products, Thor has submitted its dossier for the C(M)IT/MIT Biocidal Product Family. This submission was made approximately one month ahead of the deadline date of 1 July 2017. Thor has supported a Union Authorisation for the C(M)IT/MIT Biocidal Product Family including the product types 2, 4, 6, 11, 12 and 13, covering more than 25 applications.
The BPR concerns the placing on the market as well as the use of biocidal products. Under the BPR, (which replaced the BPD3 on 1 September 2013), all biocidal active substances contained in biocidal products are subject to an application-related evaluation which started with the establishment of the Review Programme in 2000 with a forecasted completion date in 2024. Following the approval of an individual active substance, all biocidal products containing this individual substance need to be authorised.
Thor has conducted studies and applied in use scenarios for each biocidal formulation and the summary of product characteristics (SPCs) was developed to ensure that the stringent risk assessments of the BPR are met for multiple applications, such as the preservation of paints and coatings, slimicide action in paper mills and microbial control in cooling and heating systems.
With the submission of the dossier, the product Authorisations of Thor customers were initiated either as a marketing company or for Same Biocidal Product Authorisation. Thor’s partners were able to rely on Thor’s expertise during the whole process and thus were able to save both time and money.
To learn more about the measures Thor takes to support customers with Product Authorisations under the BPR, please contact us by email: email@example.com or talk to one of our sales representatives.
1 BPR - Biocidal Products Regulation (EU) 528/2012 (BPR)
2 Reaction mass of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6) (3:1) (Mixture of C(M)IT/MIT)
3 BPD - Biocidal Products Directive (98/8/EC)